k have reviewed our w r i e n c e with r a d i o~a s s a y s of the insulin-like growth factors, IGF-I and 11, to determine their utility in the evaluation of short stature. I@-I and I1 m e masured in noml(NL) (heiqht 5-95%). no-1 short(NS) (height > 2 s . Z belm m, QI peak> 7ng/ml) and g r h h o m n e deficient (GHD)child.ren by r a d i o~o a s s a y using the NIADDK anti-serum for IGE-I and a specific antihdy to the C-peptide region of IGF-11.
An age-related boundary for IGF-I and a level of 300ng/ml for IGF-11 were used to classify values as n o m l or l w . Ilesults are given in the The effect of T and OX on GH and SmC concentrations was studied in boys with CDGA. Ten boys received OX (0.1 mg/kg/d) for 6525 d and 5 boys received T propionate (7.5 mg IM x 7 d) followed by T enanthate (100 mg IM q mo for 3 mo). Serum GH was measured in samples obtained q 20 min for 24 hr before and 6525 d into therapy. SmC levels were measured twice during the same 24 hr period before and 6555 d into therapy. The 24 hr integrated concentration of GH (ICGH) was obtained from the mean of 72 samples and compared to that obtained from a pooled sample (p=NS). A pulse of GH was recorded if the peak level rose >5 ng/ml. We found no differences in the ICGH, in the number of GH secretory episodes, or in the SmC levels in boys treated with OX. However, in bovs treated with T there were sienificant increases in the secreted daily, although OX at 0 : i mg/kg/d is without effect. This increase in GH secretion may contribute to the increased growth rate at puberty. ICGH,. the number of GH secretory episodes and in the SmC levels.
CORTISOL LEVELS AND SKIN FOLD THICKNESS IN BPD

Rx
OX T
465
Carol Luzzi, (Spon. by Leonard J. Graziani) Thomas Jefferson Univ. Hosp., Dept. Pediatrics, Phila. Some babies with BPD, a chronic disease causing significant metabolic stress, have been noted to take on a cushingoid appearance. We postulated that this appearance is a result of stress induced elevated cortisol levels and altered body fat distribution (centrallperipheral skin fold thickness). 29 infants were prospectively studied with 8am serum cortisol levels between days 4 to 10 (wk 1) and during weeks 4 and 6. Subscapular, periumbilical, and triceps skin fold measurements (SCF, PUF, and TF) were taken at wks 4 and 6. Central to peripheral fold ratios (SCFITF and PUF/TF) were calculated. At wk 6, the patients were divided into 4 groups. Gr 1, (N=7) "well infants", 4F102 <24hrs; Gr 2 (N=2) "non-pulmonary illness", fF102 <24hrs + non-pulmonary illness >48 hrs duration; Gr 3 (N=6) "acute pulmonary illness", +F102 <2 wks duration, + other illness; Gr 4 (N=14) BPD, 4F102 >2 wks duration plus xray signs of BPD + other illness. Data are presented as mean + S.D.
We conclude that testerone thera~v doubles the amount of GH n 10 5 I Group 2 does n6t have enough data for statistical analysis. Babies with BPD were compared to all non-BPD babies and groups 1 and 3 alone. Statistical analysis revealed no significant difference, p <.05, in cortisol levels or skin fold ratios. 
Fenton) U n i v e r s i t v o f South Dak markedly accelerated s k e l e t a l maturation, r e l a t i v e f a i l u i -e t o t h r i v e and dysmorphism. Since then 11 cases have been reported. With t h e exception o f an elevated testosterone i n a neonatal f emale, hormonal evaluations have been normal. We present a male w i t h Marshal 1 -Smith Syndrome w i t h abnormal adrenal androgen production. A.S. was noted a t b i r t h t o have a bone age of 2 y r s . A t age 8 mos. t h e bone age was 6 y r s . Noted were generalized h i r s u tism, prominent forehead, low s e t ears, shallow o r b i t s w i t h promi-
nent eyes, small t r i a n g u l a r upturned nose, hypoplasia o f f a c i a l bones, long, tapered f i n g e r s , i n g u i n a l testes, small scrotum and a p e n i l e l e n g t h o f 5% cm. The f o l l o w i n g were normal f o r age: T , FSH, LH, somatomedin-C, testosterone, t e s t i c u l a r response t o H C~, and androgen receptors i n c u l t u r e d s k i n f i b r o b l a s t s . Seventeen hydroxyprogesterone (17-OHP) was elevated (840 ng/dl; n l 30-100) as was androstenedione (67 ng/dl; n1<50). An ACTH s t i m u l a t i o n t e s t was done. A 30 min. increase i n 17-OHP o f 23.4 ng/dl/min. suggested an adrenal enzymatic d e f e c t and hydrocortisone 20 mg/m2/day was begun. The androstenedione decreased t o 13/ng/dl and on therapy has remained normal. ACTH s t i m u l a t i o n t e s t s were performed on both parents. The 30 min. increase i n 17-OHP was elevated i n both (father-13.8 n /dl/min; mother-8.9 ng/dl/min; n K 6 . 5 ng/dl/min) .suggesting a {eterozygous s t a t e f o r congenital adrenal hyperplasia. It i s speculated t h a t an i n h e r i t e d abnormaF i t y i n androgen production may be c o n t r i b u t o r y t o t h e osseous maturation seen i n t h e Marshal 1 -Smith Syndrome. The precise regions of the human growth hormone (hGH) molecule that mediate its biologic effects and immunoreactivity are not known. To address this issue, we have introduced mutations into the coding region of a cloned hGH gene and expressed the resulting mutants in a eukaryotic expression vector. Two clones with alterations in the DNA sequences encoding amino acids 93-96 within the hGH molecule were created by the insertion of Bam HI DNA linkers into the Mst I1 site. The hGH derived from these mutants had characteristics indistinguishable from those of wild type hGU in the NB-2 cell lactogenic assay, the IM-9 cell radioreceptor assay, and in the binding of four anti-hGH monoclonal antibodies. However, significant differences were observed between the mutants and standard human pituitary GH or hGH produced by the normal gene in the binding of polyclonal hGH antisera. Both mutants bound to the polyclonal antibody poorly but did not displace labeled standard hormone in a proportionate manner.
These results suggest that amino acids 93-96 of hGH regulate the expression of antigenic determinants that are detected by polyclonal antiserum, but these determinants are distinct from those recognized by the four monoclonal antibodies that were tested. Moreover, hGH molecules with abnormal immunologic reactivity may retain normal biologic activities in certain assays. 
